Clinical Trials Sponsored by Eva Haglind

Total 5090 results

Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fed

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil 500 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Zaleplon 10 mg Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fed

Healthy

United States
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
REVA Medical, Inc.

Completed

Safety Study of a Bioresorbable Coronary Stent (RESTORE)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Brazil
TVA Medical Inc.

Terminated

everlinQ endoAVF Post Market Study

Chronic Kidney Disease

United Kingdom, Germany, Canada
Teva Pharmaceuticals USA

Completed

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Buspirone Hydrochloride 30mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Buspirone Hydrochloride 30mg Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Actinic Keratosis

United States
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
TVA Medical Inc.

Completed

A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)

Chronic Kidney Disease (CKD)

Paraguay

Clinical Trials Sponsored by Eva Haglind

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations